API

#API #Formulation

CatSci launches API risk assessment tool  

Life sciences partner CatSci has launched a digital tool to assess the risk of a company’s active pharmaceutical ingredient (API). SmartPath is a digital tool created by CatSci to assess its customers’ API, project, and formulation data and offer them smart mitigation strategies. Companies using the platform will… Read More

#News

#API #CDMO

Onyx Scientific expands API offering 

Contract development and manufacturing organisation (CDMO) Onyx Scientific has opened a second facility in North East England, expanding its offerings.   The company’s new site doubles Onyx Scientific’s current footprint and will enable it to expand all Chemistry, Manufacturing and Controls (CMC) activities. The facility will also enable… Read More

#News

#API #FDA #GMP #Regulatory

New whitepaper: FDA guidelines for GMP of API

One of the key elements of quality control in pharmaceutical manufacturing is cGMP compliance. As your product moves closer to market, cGMP requirements change and become more stringent. Dalton Pharma Services has created a whitepaper to download, FDA Guidelines for GMP of API. Featured in this whitepaper which you… Read More

#News